Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Visible Genetics Inc.(VGIN) -- Ignore unavailable to you. Want to Upgrade?

To: Robert G. Hanah who wrote (275)	2/16/1999 4:04:00 PM
From: Dr. Godless	Read Replies (1) \| Respond to of 337

I called IR at Genevest. The guy was a little flippant and acted as if I were taking him away from his valuable TV time or something. Genevest holds 1.927 million shares of Visible. At today's quote of $19.5 U.S. and divided by the 10 million or so fully diluted shares of Genevest, the net asset value is $3.80 US. Genevest is currently quoted at $1.60-1.70 US. They also own 1.4 million shares of Pinetree Capital currently trading at 1.30 a share, which adds well over another dime to its value. Genevest has no notes out of any kind - no bank debt or debentures -- just some minor "trade debt" that has no impact on the net asset value. I asked him what the company was doing about increasing market perception of its hidden value. He said he couldn't disclose what was being undertaken, but assured me that the company will be doing something soon. He also said that Visible will be getting more favorable press over the next little while.